Odds Of Vertex's Pipeline Success Aren't Dismal As Some Fear, Bernstein Says
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) shares have come under selling pressure recently, given investor concern regarding diversity in the pipeline for this cystic fibrosis-focused biopharma.
